ArticleProstate cancer and prostatic diseases2023

Discovery of a new candidate drug to overcome cabazitaxel-resistant gene signature in castration-resistant prostate cancer by in silico screening.

Hiroshi Hongo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.